D-1211-2018 Class III Terminated

Recalled by Hetero Labs, Ltd. - Unit III — Hyderabad

FDA drug recall D-1211-2018 was initiated by Hetero Labs, Ltd. - Unit III on Sep 12, 2018 and is designated Class III. Reason for recall: Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg. The recall status is terminated (terminated Nov 29, 2018). Affected quantity: 5,424 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 3, 2018
Initiation Date
Sep 12, 2018
Termination Date
Nov 29, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,424 bottles

Product description

Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NJ, 08854, NDC 31722-596-90

Reason for recall

Presence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingled in a bottle containing Fenofibrate Tablets, USP 145 mg.

Distribution pattern

Indiana and Louisiana

Code information

Lot #: E181370, Exp. 5/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1211-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1211-2018. Report a data issue: hello@regdatalab.com.